Use of interferon-gamma release assay for latent tuberculosis infection screening in older adults exposed to tuberculosis in a nursing home

Journal of the American Geriatrics Society

Volumn 59, Issue 5, 2011, Pages 858-862

  Katsenos, Stamatis ^a   Nikolopoulou, Melita ^a   Gartzonika, Constantina ^b   Manda Stachouli, Carmen ^c   Gogali, Athena ^a   Grypaiou, Christodoula ^d   Mavridis, Anestis ^b   Constantopoulos, Stavros H ^a   Daskalopoulos, George ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^d Section of Hygiene Prefecture of Ioannina   (Greece)

Author keywords

elderly; latent tuberculosis infection; QuantiFERON TB Gold In Tube; tuberculin skin test

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CONTACT EXAMINATION; CYTOKINE RELEASE; ELDERLY CARE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS INFECTION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; OUTCOME ASSESSMENT; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MASS SCREENING; NURSING HOMES; TUBERCULIN TEST;

EID: 79956033052     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03367.x     Document Type: Article

References (30)

1. Van den Brande R., Revised guidelines for the diagnosis and control of tuberculosis: Impact on management in the elderly. Drugs Aging 2005; 22: 665-686.
2. Stead WW., Tuberculosis among elderly persons, as observed among nursing home residents. Int J Tuberc Lung Dis 1998; 2: S64-S70.
3. American Thoracic Society; Centers for Disease Control and Prevention; Council of the Infectious Disease Society of America. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
4. Pouchot J, Grasland A, Collet C, et al,. Reliability of tuberculin skin test measurement. Ann Intern Med 1997; 126: 210-214. (Pubitemid 27061574)
5. Pai M, Zwerling A, Menzies D., Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008; 149: 177-184.
6. Cellestis Limited QuantiFERON-TB Gold (in-tube method) [package insert] [on-line]. Available at Accessed December 8, 2010.
7. Luetkemeyer AF, Charlebois ED, Flores LL, et al,. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007; 175: 737-742. (Pubitemid 46536491)
8. Arend SM, Thijsen SF, Leyten EM, et al,. Comparison of two interferon-γ and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618-627. (Pubitemid 46438947)
9. Kobashi Y, Mouri K, Yagi S, et al,. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008; 133: 1196-1202. (Pubitemid 351685526)
10. Behr A, Hopewell PC, Paz EA, et al,. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998; 158: 465-469. (Pubitemid 28378174)
11. Canadian Tuberculosis Committee. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34: 1-13.
12. CDC. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010; 59 (RR-5): 1-25.
13. Haslov K, Ponce-de-Leon Rosales S, Rangel-Frausto S, et al,. Tuberculin PPD RT23: Still going strong. Int J Tuberc Lung Dis 1998; 2: 793-796.
14. van Zyl-Smit R, Pai M, Peprah K, et al,. Within-subject variability and boosting of T cell interferon-γ responses after tuberculin skin testing. Am J Respir Crit Care Med 2009; 180: 49-58.
15. NICE. Clinical guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence, 2006 [on-line]. Available at guideline Accessed February 22, 2007.
16. Rajagopalan S, Yoshikawa TT., Tuberculosis in the elderly. Z Gerontol Geriatr 2000; 33: 374-380.
17. Gisselbrecht M., Tuberculosis in elderly persons living in institutions. Rev Mal Respir 2004; 21: S106-S113.
18. Ijaz K, Dillaha J, Yang Z, et al,. Unrecognized tuberculosis in a nursing home causing death with spread of tuberculosis to the community. J Am Geriatr Soc 2002; 50: 1213-1218. (Pubitemid 34774544)
19. Forssman B, Gupta L, Mills K., A tuberculosis contact investigation involving two private nursing homes in inner western Sydney in 2004. NSW Public Health Bull 2006; 17: 44-47.
20. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005; 54 (RR-15): 1-47.
21. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom. Code of practice 2000. Thorax 1993; 48: 1257-1260.
22. Kobashi Y, Mouri K, Obase Y, et al,. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30: 945-950. (Pubitemid 351194799)
23. Nisar M, Williams CSD, Ashby D, et al,. Tuberculin testing in residential homes for the elderly. Thorax 1993; 48: 1257-1260. (Pubitemid 24009395)
24. Grzybowski S, Allen EA., The challenge of tuberculosis in decline: A study based on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis 1964; 90: 707-720.
25. Saltzman RL, Peterson PK., Immunodeficiency in the elderly. Rev Infect Dis 1987; 9: 1127-1135.
26. Behr MA, Warren SA, Salamon H, et al,. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449. (Pubitemid 29067335)
27. Pai M, Dheda K, Cunningham J, et al,. T-cell assays for the research agenda forward. Lancet Infect Dis 2007; 7: 428-438.
28. Diel R, Loddenkemper R, Meywald-Walter K, et al,. Predictive value of a whole-blood IFN- assay for the development of active TB disease. Am J Respir Crit Care Med 2008; 177: 1164-1170.
29. Diel R, Loddenkemper R, Meywald-Walter K, et al,. Comparative performance of tuberculin skin test, QuantiFERON-TB-GOLD In tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 2009; 135: 1010-1018.
30. Diel R, Nienhaus A, Loddenkemper R., Cost-effectiveness of interferon-γ-release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007; 131: 1424-1434. (Pubitemid 46762348)